MetLife secures last-minute Real Value of $53.8711 per share. The latest price of the firm is $48.08. At this time the firm appears to be undervalued. Macroaxis forecasts value of MetLife from analyzing the firm fundamentals such as Profit Margin of
7.56%, Current Valuation of 117.03B and Return On Equity of 9.12% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
May 21, 2019
MetLife is very steady asset. Calculation of real value of MetLife is based on 2 months time horizon. Increasing MetLife time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
MetLife Market CapMetLife is considered to be number one stock in market capitalization category among related companies. Market capitalization of Insurance - Life industry is now estimated at about 98.03 Billion. MetLife totals roughly 44.98 Billion in market capitalization claiming about 46% of equities under Insurance - Life industry.
|Horizon||30 Days Login to change|
MetLife is rated below average in price to earning category among related companies. It is regarded second in last dividend paid category among related companies creating about 0.19 of Last Dividend Paid per Price to Earning. The ratio of Price to Earning to Last Dividend Paid for MetLife is roughly 5.26
|Price to Earning ( times )|
|Last Dividend Paid|
|Earnings Quarterly Growth||10.20%|
|Enterprise Value To Ebitda||15.00|
|Enterprise Value To Revenue||1.69|